BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2011
View Archived Issues
Spotlight on myotonic dystrophy: Misregulated alternative BIN1 splicing linked to muscle weakness
Read More
Novel antineoplastic agents presented
Read More
Topline phase III data on HyQ in primary immunodeficiency
Read More
NVP-BEZ-235/everolimus combination displays synergistic antitumor effects in models of NSCLC
Read More
CUPID trial supports safety and efficacy of Mydicar intracoronary gene therapy for heart failure
Read More
Niclosamide inhibits protein involved in colon cancer metastasis
Read More
Rectogesic slows lymphatic transit time of snake venom
Read More
Boehringer Ingelheim patents novel chemokine CCR2 receptor antagonists
Read More
New nicotinic acetylcholine alpha7 receptor ligands presented by NeuroSearch
Read More
Novel metabotropic mGlu5 glutamate receptor modulators developed
Read More
Novartis synthesizes new orexin receptor antagonists
Read More
French universities patent new agents for herpes simplex virus infection
Read More
Evotec and UCB form drug discovery collaboration for CNS disorders
Read More
NovaBay Pharmaceuticals provides pipeline update
Read More
Sinapis Pharma completes phase I trial of methamphetamine hydrochloride
Read More
Mesoblast receives FDA clearance for phase III bone marrow regeneration trial
Read More
Novartis initiates phase II LCQ-908 trial in hepatitis C
Read More
Achillion begins phase I trial of ACH-2928 for treatment of hepatitis C
Read More
Resminostat receives FDA orphan status in hepatocellular cancer
Read More
Eisai Europe reports phase III results showing efficacy of zonisamide in newly diagnosed epilepsy
Read More
Ildong Pharmaceutical to sell pirfenidone in South Korea under license agreement with Shionogi
Read More
Genfit reports encouraging phase II data on GFT-505 in diabetes
Read More
Treatment begins in phase Ib Ampion trial in osteoarthritis of the knee
Read More
Ipsen and Institut de cancerologie Gustave Roussy sign 3-year oncology partnership
Read More
PharmaVentures to assist Avexa in out-licensing apricitabine for HIV infection
Read More
